Manufacturing Support for COVID-19
As the world struggles to contain the novel coronavirus (COVID-19) outbreak, it becomes clear that diagnostics test availability is a key constraint. To support our healthcare systems with this challenge, we need to rapidly move production resources into this area.
We at Immunodiagnostic Systems (IDS) want to play a part in the global effort fighting this pandemic. Therefore, we would like to offer our expertise and support in manufacturing ELISA kits for those companies with a COVID-19 diagnostic test that need more production capacity.
What we can provide
IDS is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients.
We can offer large scale ELISA plate production, from initial formulation to packaging, labelling and shipment in our ISO 13485 and cGMP qualified facilities in Italy and the United Kingdom.
If you would like to learn more about how we can support your manufacturing efforts or require further information, please contact us on [email protected].
Let’s work together and make the world a safer place.